Loading article…
Synapse trustee Jelena McWilliams finds $85 million gap between $265 million owed and $180 million held, affecting over 100,000 fintech users.
The court‑appointed trustee for the Synapse bankruptcy has identified an $85 million shortfall between the $265 million in customer balances and the $180 million actually held by partner banks, putting more than 100,000 fintech users at risk of prolonged loss [1].
| At a glance | |
|---|---|
| Missing funds | $85 million |
| Total customer balances | $265 million |
| Funds held by banks | $180 million |
| Affected customers | >100,000 |
Jelena McWilliams, former FDIC chair and current Cravath partner, was named trustee on May 24 and has been working with four partner banks—Evolve Bank & Trust, American Bank, AMG National Trust and Lineage Bank—to reconcile ledgers [2]. Her report, filed late Thursday, is the first independent attempt to quantify the gap, which stems from Synapse’s practice of commingling deposits across multiple institutions and using both demand‑deposit and “for benefit of” (FBO) accounts. While some users with demand‑deposit accounts have begun regaining access, those in FBO accounts face a longer wait as a full reconciliation could take weeks [1].
The trustee’s analysis notes that it is not yet known whether end‑user funds were moved among partner banks in a way that created or amplified the shortfall, leaving the origin of the missing $85 million uncertain [1]. Because the deposited funds are not part of the Synapse estate, Judge Martin Barash expressed doubt about the court’s ability to order a comprehensive payout, describing the situation as “uncharted territory” [2]. McWilliams has proposed partial payments to FBO customers to alleviate immediate hardship while preserving a reserve for later distribution, but the judge’s comments suggest no clear path forward.
McWilliams also highlighted practical obstacles: there are no funds to hire external forensic firms or former Synapse staff, and the company dismissed its last employees on May 24, limiting internal expertise for the reconciliation effort [2]. The lack of detailed information about Synapse’s brokerage and lending activities further complicates the banks’ ability to trace fund flows, extending the timeline for customers to recover their savings.
The $85 million discrepancy underscores the systemic risk posed by fintech intermediaries that rely on multiple banking partners and opaque accounting practices. Until the missing funds are traced and a court‑approved distribution plan is enacted, thousands of users remain locked out of their savings, highlighting the need for clearer regulatory oversight of fintech deposit handling.
Coverage is mostly measured — 8 of 8 reports stay neutral.
Every Monday — the token unlocks, Fed dates & catalysts set to move crypto and markets this week. So you’re never blindsided.
Free · 3-min read · one-click unsubscribe
AI-assisted synthesis by the TrendWatcher Editorial Desk · sourced from 3 outlets · Jun 18, 2026 · How we report
A report by trustee Jelena McWilliams indicates an $85 million discrepancy between the $265 million in customer balances and the $180 million held by partner banks, but the exact source of the missing funds is still unknown.
More than 100,000 customers of various fintech companies that used Synapse have been locked out of their savings accounts.
The trial showed consistent signals of benefit in functional endpoints, including improved hand grip strength and motor function, with effects persisting up to seven days after treatment ended.
Ignaseclant was reported as well tolerated, with all adverse events classified as mild or moderate and no serious adverse events or discontinuations.
NMD Pharma plans to conduct larger and longer-term studies to further evaluate ignaseclant’s efficacy and safety in Charcot‑Marie‑Tooth disease.